- Home
- AIIOW vs FLGC Comparison
AIIOW vs FLGC Comparison
Compare AIIOW & FLGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AIIOW
- FLGC
- Stock Information
- Founded
- AIIOW N/A
- FLGC 2019
- Country
- AIIOW United Arab Emirates
- FLGC United States
- Employees
- AIIOW N/A
- FLGC N/A
- Industry
- AIIOW Auto Manufacturing
- FLGC Biotechnology: Pharmaceutical Preparations
- Sector
- AIIOW Industrials
- FLGC Health Care
- Exchange
- AIIOW Nasdaq
- FLGC Nasdaq
- Market Cap
- AIIOW 19.0M
- FLGC 15.9M
- IPO Year
- AIIOW N/A
- FLGC 2021
- Fundamental
- Price
- AIIOW $0.05
- FLGC $24.89
- Analyst Decision
- AIIOW
- FLGC Strong Buy
- Analyst Count
- AIIOW 0
- FLGC 1
- Target Price
- AIIOW N/A
- FLGC $156.00
- AVG Volume (30 Days)
- AIIOW N/A
- FLGC 10.7K
- Earning Date
- AIIOW N/A
- FLGC 11-12-2025
- Dividend Yield
- AIIOW N/A
- FLGC N/A
- EPS Growth
- AIIOW N/A
- FLGC N/A
- EPS
- AIIOW N/A
- FLGC N/A
- Revenue
- AIIOW N/A
- FLGC $52,373,000.00
- Revenue This Year
- AIIOW N/A
- FLGC N/A
- Revenue Next Year
- AIIOW N/A
- FLGC $10.22
- P/E Ratio
- AIIOW N/A
- FLGC N/A
- Revenue Growth
- AIIOW N/A
- FLGC N/A
- 52 Week Low
- AIIOW N/A
- FLGC $15.15
- 52 Week High
- AIIOW N/A
- FLGC $82.29
- Technical
- Relative Strength Index (RSI)
- AIIOW N/A
- FLGC 58.44
- Support Level
- AIIOW N/A
- FLGC $22.00
- Resistance Level
- AIIOW N/A
- FLGC $23.59
- Average True Range (ATR)
- AIIOW 0.00
- FLGC 1.37
- MACD
- AIIOW 0.00
- FLGC 0.39
- Stochastic Oscillator
- AIIOW 0.00
- FLGC 98.87
About FLGC Flora Growth Corp.
Flora Growth Corp is a multi-national cannabis company that manufactures and distributes consumer packaged goods, cultivates and distributes medicinal cannabis, and distributes pharmaceutical products. Its reportable segments are: the commercial and wholesale segment (FGH and Cosechemos subsidiaries) and the house of brands segment (JustCBD, Vessel, and Kasa Wholefoods Company subsidiaries). Geographically, the company generates revenue from the United States, Germany, Australia, and the United Kingdom. It generates revenue as a distributor of pharmaceutical goods, and a manufacturer and reseller of a range of cannabis-based and complementary products.